Trial intelligence / Profile preview

Mindex: Very low dose dexamethasone to facilitate extubation in ventilator-dependent preterm babies at high risk of bronchopulmonary dysplasia

2015-005342-63Phase 2Completed

Sponsor
University of Liverpool
Start
Sep 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexamethasone in bronchopulmonary dysplasia (BPD), respiratory distress syndrome (RDS), sponsored by University of Liverpool. Started Sep 2018; status: completed.

02

Drugs

dexamethasone
03

Conditions

bronchopulmonary dysplasia (BPD)respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on 2015-005342-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005342-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call